These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27070500)

  • 1. Prediction of micafungin area under the curve data by using peak concentration: applicability and utility in antifungal therapy.
    Srinivas NR
    Future Microbiol; 2016; 11(4):485-90. PubMed ID: 27070500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients.
    Martial LC; Ter Heine R; Schouten JA; Hunfeld NG; van Leeuwen HJ; Verweij PE; de Lange DW; Pickkers P; Brüggemann RJ
    Clin Pharmacokinet; 2017 Oct; 56(10):1197-1206. PubMed ID: 28144840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.
    Mehta PA; Vinks AA; Filipovich A; Bleesing J; Jodele S; Jordan MB; Marsh R; Tarin R; Edwards S; Fearing D; Lawrence J; Davies SM
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1458-62. PubMed ID: 20546908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of micafungin in pediatric patients with invasive candidiasis and candidemia.
    Undre NA; Stevenson P; Freire A; Arrieta A
    Pediatr Infect Dis J; 2012 Jun; 31(6):630-2. PubMed ID: 22301478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micafungin concentrations in the plasma and burn eschar of severely burned patients.
    Sasaki J; Yamanouchi S; Kudo D; Endo T; Nomura R; Takuma K; Kushimoto S; Shinozawa Y; Kishino S; Hori S; Aikawa N
    Antimicrob Agents Chemother; 2012 Feb; 56(2):1113-5. PubMed ID: 22083486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential pharmacokinetic characteristics of micafungin. Experience in special populations].
    Grau Cerrato S; Luque Pardos S; Ferrández Quirante O
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():10-4. PubMed ID: 21420571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Micafungin Pharmacokinetics in Intensive Care Unit Patients.
    Lempers VJ; Schouten JA; Hunfeld NG; Colbers A; van Leeuwen HJ; Burger DM; Verweij PE; Pickkers P; Brüggemann RJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4403-9. PubMed ID: 25963988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of an elevated dosage of micafungin in premature neonates.
    Smith PB; Walsh TJ; Hope W; Arrieta A; Takada A; Kovanda LL; Kearns GL; Kaufman D; Sawamoto T; Buell DN; Benjamin DK
    Pediatr Infect Dis J; 2009 May; 28(5):412-5. PubMed ID: 19319022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of micafungin regimens by pharmacokinetic-pharmacodynamic analysis: a dosing strategy for Aspergillus infections.
    Ikawa K; Nomura K; Morikawa N; Ikeda K; Taniwaki M
    J Antimicrob Chemother; 2009 Oct; 64(4):840-4. PubMed ID: 19700475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of prophylactic micafungin in very-low-birth-weight infants.
    Kawada M; Fukuoka N; Kondo M; Okazaki K; Kusaka T; Kawada K; Itoh S
    Pediatr Infect Dis J; 2009 Sep; 28(9):840-2. PubMed ID: 19636279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic profile of micafungin when co-administered with amphotericin B in healthy male subjects.
    Undre NA; Stevenson P; Wilbraham D
    Int J Clin Pharmacol Ther; 2014 Mar; 52(3):237-44. PubMed ID: 24472403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single or 2-Dose Micafungin Regimen for Treatment of Invasive Candidiasis: Therapia Sterilisans Magna!
    Gumbo T
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S635-42. PubMed ID: 26567282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis.
    Auriti C; Falcone M; Ronchetti MP; Goffredo BM; Cairoli S; Crisafulli R; Piersigilli F; Corsetti T; Dotta A; Pai MP
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7333-7339. PubMed ID: 27697761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients.
    Walsh TJ; Goutelle S; Jelliffe RW; Golden JA; Little EA; DeVoe C; Mickiene D; Hayes M; Conte JE
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3451-9. PubMed ID: 20439610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and safety profiles of repeated-dose prophylactic micafungin in children and adolescents undergoing hematopoietic stem cell transplantation.
    Albano E; Azie N; Roy M; Townsend R; Arrieta A
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e45-50. PubMed ID: 25072363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
    Yoshikawa K; Nakazawa Y; Katsuyama Y; Hirabayashi K; Saito S; Shigemura T; Tanaka M; Yanagisawa R; Sakashita K; Koike K
    Infection; 2014 Aug; 42(4):639-47. PubMed ID: 24567233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing.
    Hope WW; Seibel NL; Schwartz CL; Arrieta A; Flynn P; Shad A; Albano E; Keirns JJ; Buell DN; Gumbo T; Drusano GL; Walsh TJ
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3714-9. PubMed ID: 17638696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of micafungin in neonates and young infants.
    Hope WW; Smith PB; Arrieta A; Buell DN; Roy M; Kaibara A; Walsh TJ; Cohen-Wolkowiez M; Benjamin DK
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2633-7. PubMed ID: 20308367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micafungin.
    Bell SG
    Neonatal Netw; 2011; 30(5):329-33. PubMed ID: 21846628
    [No Abstract]   [Full Text] [Related]  

  • 20. Maintenance of therapeutic concentrations of micafungin administered 5 days/week in a leukemic adolescent with invasive candidiasis.
    Castagnola E; Cangemi G; Barco S; Bandettini R; Dallorso S; Virga F; Dufour C
    Clin Microbiol Infect; 2014 Nov; 20(11):O975-6. PubMed ID: 24621154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.